Psychotherapeutic S
Psychotherapeutic S
Psychotherapeutic S
Amitriptyline
Amphetamine &
dextroamphetamine
Atomoxetine
Buproprion
Desipramine
Fluoxetine
Haloperidol
Lithium
Methylphenidate
Mirtazapine
Olanzapine
Phenelzine
Risperidone
Thioridazine
Venlafaxine
Amitriptyline
Antidepressant
Tricyclic
Blocks neuronal reuptake of
serotonin > norepinephrine
Blocks muscarinic & adrenergic receptors
Chronic pain
Depression
Delayed onset of
antidepressant effect >4 wks
AVOID
MAOI
SSRI
Lethargy
Sedation
Blurred vision
Constipation
Urinary retention
appetite & wt gain
Carbamazepine
Quinidine
Rifampin
Amphetamine
CNS stimulant
Sympathomimetic
amine
neuronal release of
norepinephrine
ADHD
attention span
motor restlessness
Tachycardia
HTN
Anorexia
Irritability
Insomnia
Tremor
Growth inhibition
Drug dependence
Narcolepsy
mental alertness
drowsiness & fatigue
Atomoxetine
ADHD agent
Selective NE reuptake
inhibitor
Inhibits neuronal
reuptake of NE in CNS
ADHD in children/adults
appetite
Insomnia
Levels & effects altered by
drugs that inhibit/induce
CYP2D6
Bupropion
Antidepressant
Neuronal reuptake
inhibitor
Inhibits neuronal
reuptake of DA > 5-HT
& NE
Depression
Smoking cessation
Agitation
HA
Dry mouth
N
Tremor
Impaired motor &
cognitive skills
MAOI adverse effects
Seizure risks w/
phenothiazines
Desipramine
Antidepressant
Tricyclic
Lethargy
Sedation
Blurred vision
Constipation
Urinary retention
appetite & wt gain
Depression
Chronic pain
AVOID
MAOI
SSRI
Fluoxetine
Antidepressant
SSRI
Anxiety
Drowsiness
Insomnia
Nervousness
Sexual dysfunction
Sweating
Tremor
Depression
OCD
Bulimia nervosa
Anorexia nervosa
Fibromyalgia
Panic attacks
Phobias
Prementsrual dysmorphic disorder
Active metabolite 5-7d half-life
AVOID MAOI
Haloperidol
Typical antipsychotic
Butyrophenone
Blocks D2 receptors in
mesolimbic area,
chemoreceptor trigger
zone, solitary tract, &
basal ganglia
Blocks muscarinic & adrenergic receptors
Psychotic disorders
Schizophrenia
Tourettes syn
Neuroleptic malignant
syn
Fever
Respiratory distress
Tachycardia
Seizures
Severe m. stiffness
Altered BP
Extrapyramidal rxns
Tardive dyskinesia
Blurred vision
Constipation
Dry mouth
Urinary retention
Hypotension
Lithium
Polyuria
Impaired memory
Acne
Tremor
ECG changes
GI distress
Hypothyroidism
Leukocytosis
NM toxicity w/ haloperidol
toxicity
Diuretics
NSAIDS
Fluoxetine
Methyphenidate
CNS stimulant
Sympathomimetic
amine
Tachycardia
HTN
Anorexia
Irritability
Insomnia
Tremor
Growth inhibition
Dependence
neuronal release NE
ADHD
attention span
motor restlessness
Narcolepsy
mental alertness
drowsiness &
fatigue
Mirtazapine
Antidepressant
Tetracyclic
Inhibits presynaptic 2
autoreceptors &
heteroreceptors
Depression
Appetite stimulation
AVOID MAOI
HTN, seizure, death
Olanzapine
Atypical antipsychotic
Thienobenzodiazepine
Schizophrenia
Manic episodes of biploar
Anorexia nervosa
Oral tablets contain
aspartame
Avoid in phenylketonuria
Agitation
Dizziness
Restlessness
Sedation
Amblyopia
Orthostatic hypotension
Tachycardia
Constipation
Dry mouth
Wt gain
Tremor
Phenelzine
Antidepressant
MAOI
Dizziness
Insomnia
Restlessness
Blurred vision
Orthostatic hypotension
Diarrhea
Potentially fatal
SSRI
Tricyclics
Avoid
Fluoxetine
Tyramine
HTN crisis
Tyramine
Amphetamines
Methyldopa
Levodopa
Risperidone
Atypical antipsychotic
Benzisoxazole
Schizophrenia
Psychotic disorders
Monitor pt for
neuroleptic malignant
syn
Aggressive behavior
Extrapyramidal rxns
Sleep disturbances
Insomnia
Sedation
Constipation or diarrhea
Wt gain
Thioridazine
Typical antipsychotic
Phenothiazine
Blocks D2 receptors in
mesolimbic area,
chemoreceptor trigger
zone, solitary tract, &
basal ganglia
Blocks muscarinic
receptors
Psychotic disorders
Schizophrenia
Extrapyramidal rxns
Tardive dyskinesia
Photosensitivity
Potential for V
arrhythmias & sudden
death
Retinal pigmentation
w/ high doses
melanosis
Venlafaxine
Antidepressant
Phenethylamine
Inhibits neuronal
reuptake 5-HT & NE
Depression
Generalized anxiety
disorder
AVOID MAOI
Sexual dysfunction
GI distress
Dizziness
Insomnia
Nervousness